Our BPC-157 guide covers a peptide with overlapping regenerative benefits
Coffee enemas have had a place in certain alternative medicine circles since their inception in the 1930s when Doctor Max Gerson popularised the treatment as part of his Gerson Therapy
compared the effects of cotadutide (a dual GLP-1/GCG receptor agonist), liraglutide, and obeticholic acid in two mouse models of NAFLD [amylin liver NASH (AMLN) diet mice and AMLN diet ob/ob mice] to show that cotadutide outperformed other treatments in improving major histological endpoints, i.e., hepatic steatosis, inflammation, NAS, and fibrosis
While GLP-1 medications are effective, they may cause side effects such as nausea or digestive discomfort, which usually improve over time
Patients in the NAC group also had a shorter median stay in the intensive care unit than did those in the placebo group (median 7 vs